PFIZER INC.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
Phase 3
Completed
- Conditions
- Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2013-11-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 512
- Registration Number
- NCT00474786
- Locations
- π¬π§
Pfizer Investigational Site, Newcastle upon Tyne, United Kingdom
Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors
Phase 1
Completed
- Conditions
- Sarcoma, Ewing's
- Interventions
- Drug: CP-751,871
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 65
- Registration Number
- NCT00474760
- Locations
- π¬π§
Pfizer Investigational Site, Sutton, Surrey, United Kingdom
12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: PF-00734200 10 mg QDDrug: PF-00734200 20 mg QDDrug: PF-00734200 5 mg QDDrug: PF-00734200 2 mg QDDrug: Placebo
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2010-06-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 303
- Registration Number
- NCT00473525
- Locations
- πΈπͺ
Pfizer Investigational Site, Stockholm, Sweden
Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug
Phase 1
Completed
- Conditions
- Obesity
- Interventions
- Drug: CP-945,598
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2009-08-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 17
- Registration Number
- NCT00472836
- Locations
- πΊπΈ
Pfizer Investigational Site, Miami, Florida, United States
A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients
Terminated
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Procedure: PET imaging
- First Posted Date
- 2007-05-11
- Last Posted Date
- 2009-07-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT00472264
- Locations
- πΊπΈ
Pfizer Investigational Site, St. Louis, Missouri, United States
Nasopharyngeal Streptococcus Pneumoniae Carriage
Completed
- Conditions
- Streptococcus Pneumoniae Infections
- First Posted Date
- 2007-05-10
- Last Posted Date
- 2013-11-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 9707
- Registration Number
- NCT00471822
- Locations
- π¨π³
Pfizer Investigational Site, Taoyuan, Taiwan
Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
Phase 3
Completed
- Conditions
- Carcinoma, Pancreatic Ductal
- Interventions
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2012-07-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 630
- Registration Number
- NCT00471146
- Locations
- π¬π§
Pfizer Investigational Site, Southhampton, United Kingdom
Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 83
- Registration Number
- NCT00471276
- Locations
- πΊπΈ
Pfizer Investigational Site, Everett, Washington, United States
A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product
Completed
- Conditions
- Siderosis
- Interventions
- Other: Observational Trial
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2011-02-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT00471224
- Locations
- πΊπΈ
Pfizer Investigational Site, Houston, Texas, United States
Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss
Not Applicable
Completed
- Conditions
- Obesity
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2008-09-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 350
- Registration Number
- NCT00471172
- Locations
- πΊπΈ
Pfizer Investigational Site, Milwaukee, Wisconsin, United States
Β© Copyright 2025. All Rights Reserved by MedPath